“decrease distributed program”的搜索结果，显示 231-240 项，共有 838 项

1. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation (DBS) of the dentate nucleus area for improving functional ...

2. 神经科- 临床试验- 妙佑医疗国际

   The primary purpose of this study is to create a Mayo Clinic repository for neurodegenerative disorders such as Parkinson's disease (PD), ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... decrease treatment-related side effects, and improve immune function. Information learned from this study may help researchers determine whether a ...

4. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with ...

5. 脑肿瘤项目- 临床试验- 妙佑医疗国际

   The Neuro-Oncology Program Registry and Biobank will be used for research purposes to increase our understanding of nervous system tumors. Perfusion MRI for ...

6. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... program that can be implemented and studied in the future. We aim to recruit 100 subjects (50 survivors and 50 caregivers) to the study. Inclusion Criteria ...

8. 复杂护理项目- 妙佑医疗国际

   ... reducing time away from work. ... To date, 89% of patients in the Mayo Clinic Complex Care Program rated their likelihood to recommend Mayo Clinic as “very good.

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

10. 神经科- 临床试验- 妙佑医疗国际

    VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...